Implementation of Universal Rotavirus Vaccination in Indonesia: Review Article

Background: Rotavirus is a leading cause of severe diarrhea in children under five years of age worldwide, with significant morbidity and mortality, particularly in low- and middle-income countries like Indonesia. Diarrhea in Indonesia is the second leading cause of death after pneumonia. Rotavirus is the main cause of severe diarrhea in children under five years of age (41%-58%). Because of this, in 2022 Indonesia launched a high-risk Rotavirus vaccine in 21 districts. Objective: This study aims to determine the universal use of the rotavirus vaccine in Indonesia and the impact of the rotavirus vaccine on the community. Method: Information on Implementation of Universal Rotavirus Vaccination in Indonesia: Review Article was gathered using NCBI, PubMed, Google Scholar, WHO, and the Ministry of Health. The types of data obtained in this literature review are articles, journals, and books accessed through online searches. Online search. The keywords used were ‘Rotavirus’, ‘Rotavirus Vaccine’, ‘Rotavirus Diarrhea’, and ‘Vaccine Distribution’. Result: The Rotavirus vaccine reduces the incidence of rotavirus diarrhea in children and currently the government has made rotavirus vaccine free in Indonesia.